InvestorsHub Logo
Followers 0
Posts 396
Boards Moderated 0
Alias Born 07/21/2016

Re: JB-22 post# 18672

Thursday, 04/20/2017 5:58:15 PM

Thursday, April 20, 2017 5:58:15 PM

Post# of 108192
More from IR in response to my email (just emailed to me now):

We will most likely provide updates at an analyst / investor day, probably in June. As for data, we will submit data for presentation at medical meetings once we have it. It's hard to predict exact timing. We should have most of the data you mention below presented before the end of the year.

My email:

That is disappointing, I was expecting updates on AIM2CERV, AXAL/durvalumab, phase 2 BrUOG, Mt Sinai phase 2 and prelim ADXS-HER2 data. Was only one abstract submitted?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News